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Weight-for-age z-score as a proxy marker for
diarrhoea in epidemiological studies
Wolf-Peter Schmidt,1 Sophie Boisson,1 Bernd Genser,2 Mauricio L Barreto,2
Kathy Baisley,1 Suzanne Filteau,1 Sandy Cairncross1
ABSTRACT
Background The validity of unblinded randomised trials
testing interventions against diarrhoea is severely
compromised by the potential for bias. Objective proxy
markers for diarrhoea not relying on self-report are
needed to assess the effect of interventions that cannot
be blinded. Short-term changes in weight-for-age z-score
(WAZ) may (due to catch-up growth) not be a clinically
important marker for nutritional status. However, even
a transient decrease in WAZ could indicate recent
diarrhoea, and be interpreted as the effect of an
intervention.
Methods Using data from two large vitamin A trials
from Ghana and Brazil, the immediate effect of the
cumulative diarrhoea occurrence over 14 and 28 day
time windows on WAZ was explored.
Results A very strong linear association was found
between the number of days with diarrhoea over the last
14e28 days and WAZ. In both trials, differences in
diarrhoea between the trial arms were associated with
corresponding differences in WAZ.
Conclusion Repeated WAZ measures appear to be
a suitable proxy marker for diarrhoea in children, but
have disadvantages in terms of specificity and study
power.
INTRODUCTION
Diarrhoeal diseases continue to be a major cause of
mortality and morbidity in children. Control
measures have had some success in recent years.
Treatment of diarrhoea with oral rehydration is
effective in reducing case fatality.1 Prevention has
proved more difﬁcult. It is hoped that in the future
rotavirus vaccination may contribute to reducing
diarrhoea-related mortality in poor settings.2
However, it is possible that diarrhoea will remain
a leading cause of child mortality worldwide also in
the future. Some of the most challenging global
issues, such as nutrition, environmental pollution,
population increase and climate change are not
only closely related to each other, but also have the
potential to contribute to living conditions associ-
ated with a high risk of diarrhoea.3 There is clearly
an ongoing need for large-scale epidemiological
studies to test new interventions against diarrhoea.
In the past, trials testing, for example, water,
sanitation and hygiene interventions have demon-
strated large reductions in diarrhoea incidence and
prevalence, often ranging from 30% to 50% disease
reduction (ﬁgure 1). However, the comparison of
blinded and unblinded randomised trials testing the
effect of household water treatment (one of the few
environmental interventions against diarrhoea that
can be blinded) suggests that observer and responder
bias in the collection of self-reported diarrhoea data
may be substantial.7 Even an observed reduction in
reported diarrhoea of 50% may be compatible with
no true effect (ﬁgure 1).7 A study on a portable ﬁlter
device conducted in Ethiopia found a 25% reduction
of reported diarrhoea despite very low and inconsis-
tent use, a result that is best explained by bias.8 It
mustbe assumed that results fromtrials testingother
unblinded interventions against diarrhoea, such as
hand washing or sanitation, include a similar degree
of bias. Empirical studies in other research ﬁelds, for
example, clinical epidemiology, also found strong
evidence for substantial bias due to lack of blinding.9
Public health policy decisions aiming at reducing
the burden of diarrhoea are severely compromised
by this lack of reliable data on the effect of inter-
ventions, which may lead to favouring the imple-
mentation of clinical interventions that can be
tested in double-blind randomised trials.3 Biased
effect estimates may also cause interventions
against diarrhoea to be scaled up prematurely,
perhaps drawing attention away from other,
possibly more beneﬁcial public health measures.7
Alternative measures of diarrhoea that do not
depend on self-report are needed to improve conﬁ-
dence in studies measuring the effect of unblinded
diarrhoea trials. Diarrhoea-speciﬁc or overall
mortality is a good outcome measure from the
public health perspective, but mortality studies
require a large sample size, which is beyond the
scope of most trials. Health care utilisation (pref-
erably self-initiated, not referred to by a ﬁeld
worker) has been used as an outcome measure in
the past,10 but bias in healthcare seeking behaviour
cannot be fully excluded. Other potential proxy
markers for diarrhoea include inﬂammatory
markers,11 and antibody titres against speciﬁc
organisms, but results so far have been inconclu-
sive. Also, conducting laboratory tests in large
studies is logistically challenging and cost-intensive.
Finally, the effect of an intervention on diarrhoea
may be estimated from its effect on nutritional
status. The effect of diarrhoea on weight and
height is well documented in the literature.12e16
The long-term effect of diarrhoea on height and
weight may be particularly pronounced in children
under 6 months,14 16 17 and appears to be modiﬁed
by many factors such as breast feeding.16 Weight
may be an inadequate marker for nutritional status,
because the effect of diarrhoea on weight is
thought to be rather short term and perhaps of
little clinical importance. However, if weight,
measured, for example, as weight-for-age z-scores
(WAZ), is used only as a proxy marker for diarrhoea
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such concerns are irrelevant. It does not matter whether the
observed weight loss is clinically important or largely due to
transient effects of diarrhoea such as dehydration, loss of
appetite, or an empty digestive system, and quickly reversed by
catch-up weight gain. Although most studies on the effect of
diarrhoea on nutritional status have tried to estimate the longer
term effect of diarrhoea on weight, this analysis focuses on the
immediate effect of diarrhoea on weight. The aim is to explore
whether WAZ (which can be measured quite easily by ﬁeld
workers with basic training) can be used as a proxy marker of
diarrhoea.
METHODS
Study populations
Data from two large trials testing the effect of vitamin A supple-
mentation on diarrhoeal and other illnesses were used. The trials
were conducted in northern Ghana18 and north-eastern Brazil,19
both in semi-arid low-income settings, between 1990 and 1991.
The Ghana study took place in a poor rural setting with extended
families living in compounds and practicing subsistence farming.
The study area was chosen due to a high prevalence of vitamin A
deﬁciency. All compounds in the study area were included in the
trial. All children aged 0‑60 months living in these compounds
were eligible for inclusion. The study was a dynamic cohort
including newborn children and excluding children growing older
than 60 months. The Brazil trial was conducted in Serrinha,
a town with 30 000 inhabitants 170 km north-west of Salvador,
the capital of Bahia state. At the beginning of the study, children
were identiﬁed by a census of the poorest neighbourhoods in the
area. Eligible children were between 6 and 48 months of age, and
had no active xerophthalmia, recent measles or recent vitamin A
supplementation. In both trials children were followed up for
approximately 1 year,with approximately 10%ofperson time lost
to follow-up (table 1). Socioeconomic statuswas poorer in Ghana,
where a large majority of households relied on open wells, bore
holes and rivers aswater sources. In Brazil, over 95%of households
had piped-in water supply and over 90% had electricity.
Diarrhoea measurement
Both studies aimed at obtaining continuous daily records of
diarrhoea, from which diarrhoea prevalence over the last 2 weeks
could be obtained for the purposes of this analysis. In Ghana,
weekly ﬁeld worker visits measured the daily prevalence of
diarrhoeal disease symptoms since the last visit; in Brazil ﬁeld
workers visited up to three times a week. In the Ghana dataset,
diarrhoea was deﬁned based on mothers’ deﬁnitions and local
disease perception. In the Brazil data, diarrhoea was deﬁned as
the occurrence of three or more loose stools over 24 h.
It has been recognised that the adverse effects of diarrhoea
such as malnutrition depend not so much on the number of
diarrhoea episodes, but on the duration of these episodes20 as
well as the number of days with diarrhoea over a certain period
of time, also known as the longitudinal prevalence.15 16 21
Therefore, a measure of recent diarrhoea was the number of days
with diarrhoea in an individual during a ﬁxed time window
looking back from the date on which weight was measured. In
order to focus on the short-term effect of diarrhoea on WAZ, 14-
day window was used for the primary analysis. In a secondary
Figure 1 All an illusion? Combined
estimates of the effect of environmental
health interventions on diarrhoea. The
first four estimates are from systematic
reviews including random effects meta-
analysis.4e6 The estimate of the effect
of blinded household water treatment
interventions is a simple average from
the few published and unpublished
studies,7 as no valid data on the SEs
were available. The effect size is given
for illustration only ‑ none of the blinded
studies showed any evidence for an
effect of the intervention on diarrhoea.7
Table 1 Epidemiological characteristics of the two study populations
Ghana Brazil
Number of children 1877 1209
Person years 1455 1104
Age range at baseline (months) 0e59 6e48
Diarrhoea
Incidence rate/PY 9.0 7.0
Longitudinal prevalence 17% 5%
Mean duration of episodes (days) 6.1 2.7
Mean WAZ by age at measurement
0e12 months 1.56 0.51
>12e24 months 1.86 0.89
>24e36 months 1.70 0.81
>36e48 months 1.57 0.84
>48e60 months 1.63 0.89
0e60 months 1.67 0.83
WAZ <2 30% 13%
Mean HAZ 2.39 1.30
HAZ <2 62% 25%
Mortality
Deaths (n) 77 4
Mortality rate/1000 PY 52.9 3.6
PY, person years of observation; WAZ/HAZ, weight/height-for age z-score.
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analysis, 28-day windows were also tested. Weight measure-
ments preceded by fewer than 14 days (or 28 days) of observa-
tion were excluded from the analysis.
Weight measurement
Weight and height were measured monthly for 1 year in the
Ghana study, and four times in the Brazil study (at baseline, and
then every 4 months). The ﬁrst measurement in the Brazil data
was excluded as no diarrhoea data were available prior to the
measurement.
In both trials, measurements of length/height and weight
were taken in duplicate by two independent trained ﬁeld
workers who were blinded to the intervention. The ﬁnal
measure was the mean of these two measurements. Weight was
measured by using hanging scales in Ghana and by electronic
scales in Brazil. Weight and height were transformed into z-
scores (WAZ and HAZ), indicating how many standard devia-
tions an individual child of a certain age deviates from the norm.
The WHO growth norms were used for the Ghana data (using
the WHO Anthro software http://www.who.int/childgrowth/
software/en/) and the national growth standard for Brazil
(calculated previously22). HAZ was included in the analysis as
a control for the analysis. It was expected than an effect of
diarrhoea would be seen over the last 2 weeks on WAZ but not
on HAZ.
Statistical analysis
Linear regression analysis was used with WAZ (or HAZ) as the
outcome variable and the number of diarrhoea days over the
14 days preceding the day of the weight or height measurement
as the exposure variable. The analysis was adjusted for repeated
measurement in a single child using ﬁxed effects linear regres-
sion. Specifying a ﬁxed effects model allowed exploring exclu-
sively the within-child effect of diarrhoea on WAZ/HAZ,
excluding potential confounding due to children with high risk
of diarrhoea also having lower WAZ/HAZ scores unrelated to
diarrhoea. In both Ghana and Brazil, older children had on
average lower WAZ than children under the age of 12 months.
At the same time, older children had less diarrhoea than younger
children. Therefore, age needed to be included as a confounding
variable. Age was included in the model by constructing
a restricted cubic spline (three knots), as the association between
age and diarrhoea was non-linear.
The effect of the intervention (vitamin A) on WAZ was
analysed using random effects linear regression adjusted for
repeated measurements in a child. The analysis was adjusted for
the baseline WAZ measurement prior to the intervention. The
effect of the intervention on the number of diarrhoea days over
the 14 days prior to anthropometric measurements was analysed
using random effects Poisson regression. The analysis was done
in STATA 10 (StataCorp, Texas, USA).
RESULTS
Epidemiological and growth status characteristics of the two
study populations are shown in table 1. The children in Ghana
had a higher risk of diarrhoea, underweight (WAZ<2), growth
faltering (HAZ<2) and death. The mean duration of diarrhoea
episodes was much longer in Ghana than in Brazil.
In a ﬁrst step, the number of diarrhoea days in the past
14 days was treated as a continuous variable. All analyses were
adjusted for age at the time of measurement (restricted cubic
spline), which did not inﬂuence the slope but narrowed the
conﬁdence intervals. In Ghana, WAZ declined by 0.018 with
every additional day with diarrhoea (95% CI 0.020 to 0.016),
in Brazil by 0.022 (95% CI 0.028 to 0.015). In a post hoc
analysis, a trend was found suggesting that the association
between diarrhoea and WAZ was slightly stronger in children
under 24 months compared to over 24 months (choosing
12 months of age as cut-off point showed similar results). In
Ghana, the regression coefﬁcients for children under or above
24 months were 0.019 and 0.013 respectively (test for
interaction p¼0.07). In Brazil, the regression coefﬁcients were
0.029 and 0.021 respectively (test for interaction p¼0.08).
Figure 2 shows the results of the regression analysis with the
number of diarrhoea days in the past 14 days treated as a cate-
gorical variable, with no (zero) diarrhoea days as reference. In
both study populations there is a very pronounced linear asso-
ciation between the number of days with diarrhoea and WAZ.
To test the appropriateness of the regression model, HAZ was
used instead of WAZ as the outcome variable. As expected, there
was no evidence for an association between the number of days
with diarrhoea over the last 14 days and HAZ in Ghana (coef-
ﬁcient 0.003, 95% CI 0.007 to 0.002). In Brazil, diarrhoea was
associated with a slight increase in HAZ (coefﬁcient 0.007, 95%
CI 0.001 to 0.013). Figure 3 shows the same analysis with the
Figure 2 Association between
diarrhoea in the last 14 days and
weight-for-age z-score (WAZ) in two
vitamin A trials in Ghana and Brazil.
Diarrhoea was treated as categorical
variable with 0 (zero) days of diarrhoea
in the last 14 days as reference.
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number of diarrhoea days as categorical variable (as in ﬁgure 2),
conﬁrming the lack of a negative immediate effect of diarrhoea
on HAZ in both study populations.
The association between recent diarrhoea and WAZ was also
apparent when using a 28 day window instead of a 14 day
window for recent diarrhoea. In Ghana, WAZ declined by 0.013
standard deviations with every additional day with diarrhoea
(95% CI 0.014 to 0.012), in Brazil by 0.014 SDs (95% CI
0.018 to 0.010). Figure 4 shows the results of the regression
analysis with the number of diarrhoea days in the past 28 days
treated as a categorical variable, again with no (zero) diarrhoea
days as reference, conﬁrming the linear association between
recent diarrhoea and WAZ.
Finally, it was tested whether the effect of the intervention
(vitamin A) on diarrhoea and WAZ were correlated. In Ghana,
vitamin A had no effect on diarrhoea prevalence. The overall
prevalence ratio (PR) was 1.01 (95% CI 0.89 to 1.14). However, if
follow-up time was restricted to the 14 days prior to an
anthropometric measurement, there was slight decrease in
diarrhoea in the intervention arm (PR¼0.97, table 2). The above
analyses suggested that a reduction in diarrhoea should translate
into an increase in WAZ. Accordingly, there was a slight increase
in WAZ by 0.04 in the intervention arm (table 2).
In the Brazil study, vitamin A was overall associated with
a 10% decline in diarrhoea longitudinal prevalence (proportion of
time ill) (PR¼0.90, 95% CI 0.78 to 1.03). However, if the follow-
up time is restricted to the 14 days prior to an anthropometric
measurement, the treatment arm experienced slightly higher
longitudinal prevalence (PR¼1.03, table 2). Again, there were
corresponding changes in the WAZ with a slight decrease of
0.03.
(Note that the overall results for Ghana and Brazil slightly
deviate from the published data, since a slightly different
common analysis method was used for both datasets.)
DISCUSSION
The results demonstrate a strong linear relationship between
diarrhoea in the last 2e4 weeks and weight for age z-score in
children under the age of 5, suggesting that WAZ may be
a suitable proxy marker to measure the effect of an unblinded
intervention against diarrhoea. Many previous diarrhoea trials,
especially those testing the effect of environmental health
Figure 3 Association between
diarrhoea in the last 14 days and height-
for-age z-score (HAZ) in two vitamin A
trials in Ghana and Brazil. Diarrhoea
was treated as categorical variable with
0 (zero) days of diarrhoea in the last
14 days as reference.
Figure 4 Association between
diarrhoea in the last 28 days and
weight-for-age z-score (WAZ) in two
vitamin A trials in Ghana and Brazil.
Diarrhoea was treated as categorical
variable with 0 (zero) days of diarrhoea
in the last 28 days as reference.
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interventions on diarrhoea, have either not included WAZ as an
outcome measure at all, or have measured weight only at the
beginning and end of the intervention period (eg,10 23).
According to this analysis, observing a strong reduction in self-
reported diarrhoea, as is often the case in unblinded diarrhoea
trials (ﬁgure 1), but failing to ﬁnd larger mean WAZ compared to
the control arm may speak against a true effect of an inter-
vention on diarrhoea.
The major drawback of WAZs may be their low speciﬁcity.
Many conditions, for example, fever or respiratory infections, can
acutely alter appetite, hydration, metabolism and weight. Using
WAZ as a proxy for diarrhoea is, therefore, most appropriate in
trial testing an intervention that speciﬁcally reduces diarrhoea. For
many water, sanitation and hygiene interventions (which appear
to be particularly affected by bias) this should be the case. Any
differences in WAZ between intervention and control group are
most likely due to differences in diarrhoea, but at times may to
some extent also be due to a decrease inhelminth infections.Other
interventions, for example, vitamin A or other micronutrient
supplementation (which can often be blinded)may affect illnesses
other than diarrhoea andmay, therefore, cause changes inWAZ in
the absence of an effect on diarrhoea.
The presumably low speciﬁcity of WAZ as a proxy marker for
diarrhoea is likely to affect study power. Non-differential
misclassiﬁcation in an outcome variable does not lead to bias but
lowers the precision of effect estimates. To maximise power,
WAZ needs to be measured repeatedly over the study period, for
example, every 4 weeks at the same time when collecting data
on self-reported diarrhoea. Study power can further be
strengthened by adjusting the analysis for the baseline WAZ
before the intervention, as done in this analysis. Study power
will depend on many factors, such as diarrhoea prevalence,
prevalence of other diseases causing acute weight loss (which
may lower precision), and the proportion of diarrhoea episodes
promptly treated with oral rehydration (which should limit
acute weight loss).
Weight-for-age z-scores are relatively easy to measure
compared, for example, to laboratory markers, and should
require a smaller sample size compared to objective but rare
outcomes such as mortality. Weight measurements should be
taken following a strict protocol and standardised equipment to
minimise measurement error.24 Such measures add to the
logistics of diarrhoea trials. There is also the risk of observer bias,
if the ﬁeld worker taking the weight measurement cannot be
blinded to the intervention. However, the risk of bias seems
much smaller compared to self-reported diarrhoea.
The relationship between diarrhoea and nutritional status has
been subject to intensive research. This analysis does not aim at
reinventing the wheel, but simply takes a slightly different
perspective by focusing on the immediate effect of diarrhoea on
WAZ. The observed strong short-term effectmay not be clinically
important. Regained appetite and rehydration after an episode
may quickly reverse weight loss. It is, therefore, important not to
overinterpret any changes inWAZwith respect to the effect of an
intervention on malnutrition. Applying WAZ as suggested here
largely concerns the effect of an intervention on diarrhoea.
Further, WAZ is unlikely to substantially contribute to the
interpretation of observational studies on diarrhoea. Here, the
major challenge in the analysis lies in the very large potential for
socioeconomic confounding, which is difﬁcult if not impossible
to address analytically.25 WAZ may be no less affected by
confounding than self-reported diarrhoea.
This analysis was restricted to children under the age of
5 years. Presumably, diarrhoea acutely affects weight also in
older individuals. Often, it may be less practical to take repeated
weight measures in adolescents and adults especially if the
protocol requires weight measures with only limited clothing.
Taking measures with clothes on should in most cases provide
unbiased estimates between intervention and control group but
increases the SE.
The ideal approach to conﬁrm the validity of WAZ as a proxy
marker for diarrhoea would be to include repeated WAZ
measures as a secondary outcome measure in a double-blind
randomised trial of an intervention that turns out to be effective
in reducing reported diarrhoea. In a blinded trial, the estimate of
the reduction in reported diarrhoea should be unbiased, as
should be the effect of the intervention on WAZ. Perhaps, future
vaccine trials such as rotavirus vaccination will provide such an
opportunity.
In conclusion, repeated measures of weight-for-age z-score
appear to be a suitable and relatively objective proxy marker for
diarrhoea in unblinded trials, but have disadvantages in terms of
speciﬁcity and study power. Wherever possible, blinding an
intervention and using reported diarrhoea or mortality is still the
method of choice.7 Given that results of unblinded trials on
reported diarrhoea may have little or even no validity, demon-
strating the presence or absence of changes in WAZ could allow
improvement of the evidence base of diarrhoea trials, especially
those testing complex environmental interventions.
What this study adds
< In this analysis of two large randomised trials it was found
that repeated measures of weight-for-age z-score could be
used as a proxy marker for recent diarrhoea experience, even
if it may have little clinical importance as a measure for
nutritional status.
Table 2 Effect of the intervention (vitamin A) on diarrhoea in the
14 days before measurement of weight, and WAZ adjusted for baseline
WAZ
Study
Diarrhoea
LP
Diarrhoea
PR
(95% CI) WAZ
WAZ
difference
(95% CI)
Ghana
Control 17.7% 1.71
Vitamin A 17.3% 0.97
(0.86 to 1.10)
1.67 +0.04
(0.01 to 0.09)
Brazil
Control 4.9% 0.82
Vitamin A 5.1% 1.03
(0.82 to 1.29)
0.86 0.03
(0.06 to 0.00)
LP, longitudinal prevalence (¼proportion of time ill); PR, (longitudinal) prevalence ratio.
What is already known on this subject
< Unblinded randomised trials testing interventions against
diarrhoea provide highly biased effect estimates when
relying on self-report.
< Proxy markers for diarrhoea are needed to reinstall confidence
in diarrhoea trials and prevent inadequate health policy
decisions.
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